Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Palisade Bio Inc (PALI)

Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Palisade Bio Inc 7750 El Camino Real Suite 2A Carlsbad CA 92009 USA

www.palisadebio.com Employees: 9 P: 858-704-4900

Description:

Palisade Bio Inc. is a late-stage biopharma company advancing therapies which help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio Inc., formerly known as Seneca Biopharma Inc., is based in CARLSBAD, Calif.

Key Statistics

Overview:

Market Capitalization, $K 3,244
Enterprise Value, $K -9,026
Shares Outstanding, K 1,329
Annual Sales, $ 250 K
Annual Net Income, $ -12,300 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,490 K
EBIT, $ -14,760 K
EBITDA, $ -14,760 K
60-Month Beta 1.36
% of Insider Shareholders 3.28%
% of Institutional Shareholders 11.79%
Float, K 1,286
% Float 96.72%
Short Volume Ratio 0.60

Growth:

1-Year Return -72.32%
3-Year Return -99.86%
5-Year Return -99.94%
5-Year Revenue Growth -3.85%
5-Year Earnings Growth 99.91%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.32 on 11/12/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -13.98
EPS Growth vs. Prev Qtr 30.12%
EPS Growth vs. Prev Year 68.42%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 04/08/24

PALI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -148.51%
Return-on-Assets % -115.16%
Profit Margin % -4,920.00%
Debt/Equity 0.04
Price/Sales 12.92
Price/Cash Flow N/A
Price/Book 0.49
Book Value/Share 4.97
Interest Coverage -614.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar